Institutional & Family Asset Management’s Inspire Medical Systems INSP Stock Holding History

Institutional & Family Asset Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$397	–	729
2023 Q3	$397	Hold	2	–	–	﹤0.01%	677
2023 Q2	$649	Hold	2	–	–	﹤0.01%	660
2023 Q1	$468	Hold	2	–	–	﹤0.01%	676
2022 Q4	$504	Hold	2	–	–	﹤0.01%	658
2022 Q3	$0	Hold	2	–	–	﹤0.01%	737
2022 Q2	$0	Sell	2 -2	-50%	-$399	﹤0.01%	754
2022 Q1	$1K	Hold	4	–	–	﹤0.01%	697
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	724
2021 Q3	$1K	Sell	4 -25	-86%	-$5.22K	﹤0.01%	841
2021 Q2	$6K	Hold	29	–	–	﹤0.01%	677
2021 Q1	$6K	Buy	29 +18	+164%	+$3.83K	﹤0.01%	655
2020 Q4	$2K	Hold	11	–	–	﹤0.01%	768
2020 Q3	$1K	Hold	11	–	–	﹤0.01%	791
2020 Q2	$1K	Buy	+11	New	+$846	﹤0.01%	781

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Institutional & Family Asset Management's INSP Position: Q4 2023 in Review

Institutional & Family Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 2 shares — an estimated $397 sold.

Institutional & Family Asset Management first reported a position in INSP in Q2 2020 and held it in 14 quarters. The position peaked at $6K in Q2 2021. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

Institutional & Family Asset Management reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
Institutional & Family Asset Management sold 2 Inspire Medical Systems shares in Q4 2023, an estimated $397.
Institutional & Family Asset Management first reported a position in Inspire Medical Systems in Q2 2020 and held it in 14 quarters.
Institutional & Family Asset Management's Inspire Medical Systems position peaked at $6K in Q2 2021.
343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Institutional & Family Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.